# Olmesartan medoxomil

## Olmetec 40mg

| TAH Drug Code      | [OOLM](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OOLM)                                                                                                                                                                                                                                        |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Hypertension                                                                                                                                                                                                                                                                                                |
| Dosing             | HTN: initial 20mg QD, after 2weeks may titrate up to 40mg QD.                                                                                                                                                                                                                                               |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                               |
| Contraindications  | Concomitant use of Olmetec with Aliskiren-containing products in patients with diabetes or renal impairment (GFR < 60 mL/min/1.73 m2).                                                                                                                                                                      |
| Adverse Effects    | 1% to 10%: Central nervous system: Dizziness, headache Endocrine & metabolic: Hyperglycemia, hypertriglyceridemia Gastrointestinal: Diarrhea Neuromuscular & skeletal: Back pain, CPK increased Renal: Hematuria Respiratory: Bronchitis, pharyngitis, rhinitis, sinusitis Miscellaneous: Flu-like syndrome |
| Pregnancy          | Human Data Suggest Risk in 2nd and 3rd Trimesters                                                                                                                                                                                                                                                           |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                               |
| More Info          | [UpToDate](https://www.uptodate.com/contents/olmesartan-drug-information)                                                                                                                                                                                                                                   |

